1-Ethylpyrazole-4-boronic Acid

Catalog No.: 
ACSPVD716
CAS No.: 
847818-56-8
Molecular Formula: 
C5H9BN2O2
Molecular Weight: 
139.95
1-Ethylpyrazole-4-boronic Acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$74.00In stockInquiry
5g98%$258.00In stockInquiry
25g98%$1238.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Ethylpyrazole-4-boronic Acid
IUPAC Name1-Ethylpyrazole-4-boronic Acid
MDL No.MFCD10703521
Molecular FormulaC5H9BN2O2
Molecular Weight139.95
SMILESCCN1N=CC(B(O)O)=C1
InChI KeyIIBSDEGSGLVNOY-UHFFFAOYSA-N
SynonymSY024901 | 1-Ethylpyrazole-4-boronic acid;(1-Ethyl-1H-pyrazol-4-yl)boronic acid;1-Ethylpyrazole-4-boronic Acid | MFCD10703521 | AKOS010942748 | DTXSID90466035 | IIBSDEGSGLVNOY-UHFFFAOYSA-N | W18354 | Boronic acid, (1-ethyl-1H-pyrazol-4-yl)- | SCHEMBL53213
CAS No.847818-56-8
PubChem CID11446376

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSPVD716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKORI820 route compound structure diagram
    ACKORI820847818-70-6In Stock
  2. Then
  3. ACSPVD716 route product structure diagram
    ACSPVD716847818-56-8In Stock
Inquiry

2. ACSPVD716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCWX846 route compound structure diagram
    ACRCWX846763120-58-7In Stock
  4. Then
  5. ACSPVD716 route product structure diagram
    ACSPVD716847818-56-8In Stock
Inquiry

3. ACSPVD716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSPVD716 route product structure diagram
    ACSPVD716847818-56-8In Stock
Inquiry

Comments (0)